Clinical Trials Directory

Trials / Completed

CompletedNCT04705168

Study of the Nevisense Device to Assess Atypical Skin Lesions

Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN)

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNevisense electrical impedance spectroscopyEach participants will undergo Nevisense electrical impedance spectroscopy in order to characterize the electrical impedance spectroscopy scores of nevi in patients with ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter

Timeline

Start date
2021-01-08
Primary completion
2025-11-18
Completion
2025-11-18
First posted
2021-01-12
Last updated
2025-11-20

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04705168. Inclusion in this directory is not an endorsement.